A citation-based method for searching scientific literature

R J Nijveldt, T Teerlink, M P C Siroen, A A van Lambalgen, J A Rauwerda, P A M van Leeuwen. Clin Nutr 2003
Times Cited: 134







List of co-cited articles
767 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.
P Vallance, A Leone, A Calver, J Collier, S Moncada. Lancet 1992
41

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
R J Nijveldt, T Teerlink, B Van Der Hoven, M P C Siroen, D J Kuik, J A Rauwerda, P A M van Leeuwen. Clin Nutr 2003
192
28

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.
Vinod Achan, Michael Broadhead, Mohammed Malaki, Guy Whitley, James Leiper, Raymond MacAllister, Patrick Vallance. Arterioscler Thromb Vasc Biol 2003
461
26

The human liver clears both asymmetric and symmetric dimethylarginine.
Michiel P C Siroen, Joost R M van der Sijp, Tom Teerlink, Cors van Schaik, Robert J Nijveldt, Paul A M van Leeuwen. Hepatology 2005
78
32

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Ken Y Lin, Akira Ito, Tomoko Asagami, Philip S Tsao, Shanthi Adimoolam, Masumi Kimoto, Hideaki Tsuji, Gerald M Reaven, John P Cooke. Circulation 2002
522
25

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
R H Böger, S M Bode-Böger, A Szuba, P S Tsao, J R Chan, O Tangphao, T F Blaschke, J P Cooke. Circulation 1998
951
24

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
C Zoccali, S Bode-Böger, F Mallamaci, F Benedetto, G Tripepi, L Malatino, A Cataliotti, I Bellanuova, I Fermo, J Frölich,[...]. Lancet 2001
839
23

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
A Ito, P S Tsao, S Adimoolam, M Kimoto, T Ogawa, J P Cooke. Circulation 1999
548
22

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
Paloma Lluch, Belén Torondel, Pascual Medina, Gloria Segarra, Juan A Del Olmo, Miguel A Serra, José M Rodrigo. J Hepatol 2004
84
26

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.
E I Closs, F Z Basha, A Habermeier, U Förstermann. Nitric Oxide 1997
318
22


Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Fredrik Palm, Maristela L Onozato, Zaiming Luo, Christopher S Wilcox. Am J Physiol Heart Circ Physiol 2007
230
22

ADMA metabolism and clearance.
Tom Teerlink. Vasc Med 2005
121
19

ADMA and oxidative stress.
Karsten Sydow, Thomas Münzel. Atheroscler Suppl 2003
313
19

Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis.
Rajeshwar P Mookerjee, Mohammed Malaki, Nathan A Davies, Stephen J Hodges, R Neil Dalton, Charles Turner, Sambit Sen, Roger Williams, James Leiper, Patrick Vallance,[...]. Hepatology 2007
81
23

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia.
Robert J Nijveldt, Tom Teerlink, Coen van Guldener, Hubert A Prins, Antonie A van Lambalgen, Coen D A Stehouwer, Jan A Rauwerda, Paul A M van Leeuwen. Nephrol Dial Transplant 2003
75
24

The transplanted liver graft is capable of clearing asymmetric dimethylarginine.
Michiel P C Siroen, Michiel C Warlé, Tom Teerlink, Robert J Nijveldt, Ernst J Kuipers, Herold J Metselaar, Hugo W Tilanus, Dirk J Kuik, Joost R M van der Sijp, Sybren Meijer,[...]. Liver Transpl 2004
35
51

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.
J M Leiper, J Santa Maria, A Chubb, R J MacAllister, I G Charles, G S Whitley, P Vallance. Biochem J 1999
379
18


Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure.
Rajeshwar P Mookerjee, R Neil Dalton, Nathan A Davies, Stephen J Hodges, Charles Turner, Roger Williams, Rajiv Jalan. Liver Transpl 2007
58
31


The DDAH/ADMA/NOS pathway.
Cam T L Tran, James M Leiper, Patrick Vallance. Atheroscler Suppl 2003
226
17

Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis.
P Vallance, A Leone, A Calver, J Collier, S Moncada. J Cardiovasc Pharmacol 1992
351
16


The clinical significance of asymmetric dimethylarginine.
Michiel P C Siroen, Tom Teerlink, Robert J Nijveldt, Hubert A Prins, Milan C Richir, Paul A M van Leeuwen. Annu Rev Nutr 2006
92
16


Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
Jan T Kielstein, Burcu Impraim, Solveig Simmel, Stefanie M Bode-Böger, Dimitrios Tsikas, Jürgen C Frölich, Marius M Hoeper, Hermann Haller, Danilo Fliser. Circulation 2004
312
15

Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
Dan Wang, Pritmohinder S Gill, Tinatin Chabrashvili, Maristela L Onozato, Julie Raggio, Margarida Mendonca, Kathryn Dennehy, Min Li, Paul Modlinger, James Leiper,[...]. Circ Res 2007
113
15

Cellular ADMA: regulation and action.
Tom Teerlink, Zaiming Luo, Fredrik Palm, Christopher S Wilcox. Pharmacol Res 2009
174
15

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis.
R J Nijveldt, T Teerlink, P A M van Leeuwen. Clin Nutr 2003
67
20


Does ADMA cause endothelial dysfunction?
J P Cooke. Arterioscler Thromb Vasc Biol 2000
457
13

Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
A Tojo, W J Welch, V Bremer, M Kimoto, K Kimura, M Omata, T Ogawa, P Vallance, C S Wilcox. Kidney Int 1997
172
13

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Markus C Stühlinger, Fahim Abbasi, James W Chu, Cindy Lamendola, Tracey L McLaughlin, John P Cooke, Gerald M Reaven, Philip S Tsao. JAMA 2002
471
13

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Wim Laleman, Anita Omasta, Marc Van de Casteele, Marcel Zeegers, Ingrid Vander Elst, Lien Van Landeghem, Tamara Severi, Jos van Pelt, Tania Roskams, Johan Fevery,[...]. Hepatology 2005
59
22

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
Hayan Dayoub, Vinod Achan, Shanthi Adimoolam, Johannes Jacobi, Marcus C Stuehlinger, Bing-yin Wang, Philip S Tsao, M Kimoto, Patrick Vallance, Andrew J Patterson,[...]. Circulation 2003
276
13

Disruption of methylarginine metabolism impairs vascular homeostasis.
James Leiper, Manasi Nandi, Belen Torondel, Judith Murray-Rust, Mohammed Malaki, Bernard O'Hara, Sharon Rossiter, Shelagh Anthony, Melanie Madhani, David Selwood,[...]. Nat Med 2007
300
13

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans.
Robert J Nijveldt, Paul A M Van Leeuwen, Coen Van Guldener, Coen D A Stehouwer, Jan A Rauwerda, Tom Teerlink. Nephrol Dial Transplant 2002
82
14


Accumulation of symmetric dimethylarginine in hepatorenal syndrome.
Paloma Lluch, Maria D Mauricio, José M Vila, Gloria Segarra, Pascual Medina, Juan A Del Olmo, José M Rodrigo, Miguel A Serra. Exp Biol Med (Maywood) 2006
47
25


Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.
J Murray-Rust, J Leiper, M McAlister, J Phelan, S Tilley, J Santa Maria, P Vallance, N McDonald. Nat Struct Biol 2001
181
12

Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function.
Arturo J Cardounel, Hongmei Cui, Alexandre Samouilov, Wesley Johnson, Patrick Kearns, Ah-Lim Tsai, Vladomir Berka, Jay L Zweier. J Biol Chem 2007
186
12

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Renate Schnabel, Stefan Blankenberg, Edith Lubos, Karl J Lackner, Hans J Rupprecht, Christine Espinola-Klein, Nicole Jachmann, Felix Post, Dirk Peetz, Christoph Bickel,[...]. Circ Res 2005
271
11


Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
H Miyazaki, H Matsuoka, J P Cooke, M Usui, S Ueda, S Okuda, T Imaizumi. Circulation 1999
617
11


Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.
R J MacAllister, H Parry, M Kimoto, T Ogawa, R J Russell, H Hodson, G S Whitley, P Vallance. Br J Pharmacol 1996
323
11

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.
Jan T Kielstein, Shelley R Salpeter, Stefanie M Bode-Boeger, John P Cooke, Danilo Fliser. Nephrol Dial Transplant 2006
262
11

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension.
A Surdacki, M Nowicki, J Sandmann, D Tsikas, R H Boeger, S M Bode-Boeger, O Kruszelnicka-Kwiatkowska, F Kokot, J S Dubiel, J C Froelich. J Cardiovasc Pharmacol 1999
339
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.